Pregled bibliografske jedinice broj: 329784
Selective targeting of photodynamic sensitisers to tumour tissue
Selective targeting of photodynamic sensitisers to tumour tissue // 1st Conference of the European Platform for Photodynamic Medicine (EPPM) : abstracts ; u: Photodiagnosis and Photodynamic Therapy 5(2008) (1) 62-96 / Moghissi, Kevyan (ur.).
Oxford: Elsevier, 2008. str. 62-63 (plenarno, nije recenziran, sažetak, znanstveni)
CROSBI ID: 329784 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Selective targeting of photodynamic sensitisers to tumour tissue
Autori
Boyle, Ross W. ; Greenman, John ; Pesa, Nela ; Smith, Karen ; Cochon, Nicole ; Leconte, Roger ; van Lier, Johan ; Huntig, Darel
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
1st Conference of the European Platform for Photodynamic Medicine (EPPM) : abstracts ; u: Photodiagnosis and Photodynamic Therapy 5(2008) (1) 62-96
/ Moghissi, Kevyan - Oxford : Elsevier, 2008, 62-63
Skup
Conference of the European Platform for Photodynamic Medicine (1 ; 2008)
Mjesto i datum
Dubrovnik, Hrvatska, 24.03.2008. - 27.03.2008
Vrsta sudjelovanja
Plenarno
Vrsta recenzije
Nije recenziran
Ključne riječi
Photodynamic therapy ; Porphyrin ; Bioconjugation
Sažetak
A wide range of PDT sensitisers are now available and these vary in wavelength of activation, physicochemical properties and photodynamic activity in vivo. One parameter critical to the clinical outcome of PDT is the localised concentration of photosensitiser in the target tissue at the time of treatment, and the relative ratio of this tumoural concentration to that in surrounding peritumoural tissue. Most PDT sensitisers currently used in the clinic have relatively poor tumour: peritumoural tissue ratios, with values for intravenously administered drug very rarely achieving >100: (1) significant improvements in this important parameter, and hence clinical outcomes, are unlikely to be achieved by simple manipulation of photosensitiser structure. It may be possible, however, by the use of delivery vehicles, such as liposomes and/or covalent attachment of the photosensitiser to biologically active molecules with affinity for cell surface structures that are over-expressed on tumour tissue. In this paper the requirements for targeting will briefly be discussed and in vitro, mechanistic, and in vivo data relating to bioconjugates of PDT sensitisers with monoclonal antibodies will be presented.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti
Napomena
Rad/časopois je indeksiran i u: JCR/Science Edition ; National Library of Medicine.
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Scopus
- MEDLINE